SLB vs TMO: Which Is the Better Buy?
Side-by-side comparison of SLB N.V. and Thermo Fisher Scientific Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-04.
SLB N.V. · Energy
$56.15
+68.7% upside to fair value
Grade B
VS
Thermo Fisher Scientific Inc. · Healthcare
$462.60
+10.1% upside to fair value
Grade B
QuantHub Verdict
SLB has more upside to fair value
(+68.7%).
SLB trades at a lower forward P/E
(24.3x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
SLB |
TMO |
| Current Price |
$56.15 |
$462.60 |
| Fair Value Estimate |
$94.71 |
$509.20 |
| Upside to Fair Value |
+68.7%
|
+10.1%
|
| Market Cap |
$84.3B |
$171.9B |
| Forward P/E |
24.3x
|
25.1x
|
| EV / EBITDA |
17.5x
|
19.0x
|
| Price / Sales |
2.4x
|
3.8x
|
| Price / FCF |
17.6x
|
25.5x
|
| Revenue Growth YoY |
+2.7%
|
+6.2%
|
| Gross Margin |
13.6%
|
39.4%
|
| Operating Margin |
11.5%
|
17.8%
|
| Return on Equity |
12.2%
|
13.3%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
5.69%
|
3.92%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
SLB N.V. is the world's largest oilfield services company operating primarily in the energy sector with a focus on oil and gas equipment and services. The company benefits from a diversified revenue base across well construction, production systems, reservoir characterization, and digital integration, with fiscal year 2024 revenues totaling over $37 billion. Despite modest revenue growth of 2.7% …
Thermo Fisher Scientific Inc. operates in the healthcare sector, specializing in medical diagnostics and research tools across four main segments: Laboratory Products and Biopharma Services, Life Sciences Solutions, Analytical Instruments, and Specialty Diagnostics. The company demonstrates medium business quality with steady revenue growth of 6.2% and earnings growth of 9.6% in the most recent q…
Accumulation Zones
| Metric |
SLB |
TMO |
| Zone Low |
$71.03 |
$381.90 |
| Zone High |
$80.50 |
$432.82 |
| In Buy Zone? |
Yes
|
No
|